University of Toronto tests confirm first mask that deactivates COVID-19
The mask's external surface deactivates 99% of the coronavirus suspension within minutes, according to research
MIRABEL, Que. — i3 BioMedical Inc., a Quebec-based manufacturer of medical tape and masks, announced on July 14 that a team of scientists at the University of Toronto tested and established that the virus SARS-CoV-2, which causes COVID-19, cannot be recovered after being applied to the TrioMed Active mask.
According to the research, the surgical mask’s external surface deactivates 99% of coronavirus suspension within minutes.
“The TrioMed Active Mask is the first and only respiratory protection that is scientifically proven to deactivate the virus causing COVID-19, therefore drastically reducing the risk of contamination for the wearer”, said Pierre Jean Messier, founder and CEO of i3 Biomedical Inc., in a prepared statement. “The resulting products are used by the medical community around the world and have been tested by independent laboratories to kill numerous microbes, such as MRSA, VRE, E-Coli, Staphylococcus Aureus, Influenza Virus and now SARS-CoV-2. This third-party scientific testing confirms TrioMed’s leading position in medical antimicrobial technology available in the global fight against COVID-19.”
Features and benefits of the TrioMed Active mask include:
- Active antimicrobial protection of the mask outer layer deactivates >99% of the Coronavirus SARS 2 and Influenza virus H1N1
- Viral filtration efficiency (VFE) > 99.9%
- Bacterial filtration efficiency (BFE) > 99.9%
- Five-year shelf life